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Background:  Gestational diabetes mellitus (GDM) is known to increase the risk of cardiovascular diseases. Measuring the ca-
rotid artery intimal-medial thickness (CIMT) is a non-invasive technique used to evaluate early atherosclerosis and to predict 
future cardiovascular diseases. We examined the association between CIMT and cardiovascular risk factors in young Korean 
women with previous GDM. 
Methods:  One hundred one women with previous GDM and 19 women who had normal pregnancies (NP) were recruited be-
tween 1999 and 2002. At one year postpartum, CIMT was measured using high-resolution B-mode ultrasonography, and oral 
glucose tolerance tests were performed. Fasting glucose, glycated hemoglobin A1c (HbA1c), insulin levels and lipid profiles were 
also measured. CIMTs in the GDM and NP groups were compared, and the associations between CIMT and cardiovascular risk 
factors were analyzed in the GDM group. 
Results:  CIMT results of the GDM group were not significantly different from those of the NP group (GDM, 0.435±0.054 mm; 
NP, 0.460±0.046 mm; P=0.069). In the GDM group, a higher HbA1c was associated with an increase in CIMT after age adjust-
ment (P=0.011). CIMT results in the group with HbA1c >6.0% were higher than those of the normal HbA1c (HbA1c ≤6.0%) 
(P=0.010). Nine of the patients who are type 2 diabetes mellitus converters within one year postpartum but showed no signifi-
cant difference in CIMT results compared to NP group.
Conclusion:  Higher HbA1c is associated with an increase in CIMT in women with previous GDM. However, CIMT at one year 
postpartum was not increased in these women compared to that in NP women. 
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INTRODUCTION
Gestational diabetes mellitus (GDM) is a subtype of diabetes 
that occurs during pregnancy, and its prevalence in females 
who have been pregnant is 3% to 8% worldwide. A Korean 
survey showed that the prevalence of GDM is 2.2% [1]. Given 
that the number of obese and older pregnant women is increas-
ing, the number of cases of gestational diabetes is continuously 
increasing as well [2]. Women who have been diagnosed with 
gestational diabetes have a high probability of developing type 
2 diabetes after giving birth, and the incidences of atheroscle-
rosis and cardiovascular disease risk factors are also higher 
than those in normal women [3,4]. 
  Recently, a study to predict or diagnose cardiovascular dis-
ease was performed by measuring carotid intimal-medial thick-
ness (CIMT). Studies have shown that CIMT tends to increase 
with age, and that CIMT values of smokers and patients with 
dyslipidemia, hypertension, and type 2 diabetes are increased 
compared with those of control groups [5-10]. In addition, in 
individuals with thicker CIMTs, the risk of stroke and coro-
nary artery disease is known to be higher [11-13]. 
  The association between GDM and CIMT has not yet been 
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clearly established. However, females who have a history of 
GDM have been reported to have increased CIMTs compared 
to those of females with normal pregnancies [14,15]. On the 
other hand, in a comparison of carotid and femoral artery in-
timal-medial thickness (IMT) in females who had insulin re-
sistance associated with pre-eclampsia, Blaauw et al. [16] re-
ported increased femoral artery IMTs in these females com-
pared to those of the normal pregnancy group, and that there 
was no significant difference between the two groups in CIMT 
value. 
  In this study, the CIMTs of Korean women with a history of 
gestational diabetes were measured using a high-resolution B-
mode ultrasound. Results were examined to determine if there 
was a difference between the CIMT of women with a history 
of GDM and that of women who had normal pregnancies and 
if there is a connection among CIMT, cardiovascular risk fac-
tors and glucose intolerance in women with history of GDM. 
METHODS
Target group
This study was performed between January 1999 and Decem-
ber 2002 with females who were diagnosed with gestational 
diabetes between the 24th and 28th week of pregnancy at the 
Department of Endocrinology and Metabolism Internal Med-
icine, Cheil General Hospital. Among the diagnosed patients, 
101 agreed to participate in this study. The gestational diabetes 
diagnostic criteria used in this study are those recommended 
at the Third International Workshop-Conference on GDM 
[17]. The control group (normal pregnancy, NP) was com-
prised of women who had a negative result on gestational dia-
betes screening tests performed during a previous pregnancy. 
A total of 19 females were enrolled who had no family history 
of diabetes. There were no statistical differences in age or body 
mass index (BMI) between the two study groups.
  This study was approved by the Institutional Review Board 
of Seoul National University Hospital. The study participants 
received a summary of the study purpose and method and 
submitted written consent prior to participation in the study. 
Study method
One year after women with a history of GDM gave birth, and 
one to two years after women in the control group gave birth, 
CIMT and cardiovascular risk indicators were measured. Body 
measurements, including height, weight and waist and hip cir-
cumference, were collected from all subjects. The area of ab-
dominal fat was measured using a CT scan (Somatom Sensa-
tion 16; Siemens, Erlangen, Germany), an image was taken at 
the navel with 10 mm thickness and the areas between -250 to 
-50 Hounsfield units were measured. The images were edited 
to maintain only the portion containing the innermost abdom-
inal muscles, while the rest was deleted, and the internal fat 
was used for measurements.
  A 75 g oral glucose tolerance test was performed after an 
eight hour fast, and fasting plasma glucose, insulin, glycated 
hemoglobin and plasma lipid concentrations were measured. 
The plasma glucose levels were measured using the oxidase 
method YSI 2300 STAT (Yellow Springs Instrument Co., Yel-
low Springs, OH, USA), glycated hemoglobin was measured 
using the principles of a variant of ion-exchange high perfor-
mance liquid chromatography (Bio-Rad Laboratories, Hercu-
les, CA, USA) and plasma insulin concentration was measured 
using a human-specific radioimmunoassay kit (Linco Research, 
St. Charles, MO, USA). Total cholesterol, triglycerides, and 
high density lipoprotein/low density lipoprotein cholesterol 
(HDL-C/LDL-C) levels were measured using a Hitachi 747 
autoanalyzer (Hitachi Ltd., Tokyo, Japan), and lipoprotein 
concentration was calculated using the Friedewald formula: 
([total cholesterol–HDL-C–triglyceride]/5) [18]. The homeo-
stasis model assessment of insulin resistance (HOMA-IR) was 
used as an indicator of insulin resistance and was calculated 
using the following formula: fasting plasma glucose (mmol/
L)×fasting plasma insulin (mU/L)/22.5 [19]. 
Carotid IMT measurement
One technician measured CIMTs of all subjects using a high-
resolution B-mode ultrasound on each side of the carotid ar-
tery. Starting 1 cm from the proximal end of the left and right 
carotid arteries, the CIMT was measured at ten 1 mm inter-
vals, for a total of 20 locations on the distal walls, using a Dig-
matic calipus (CD-15B; Mitutoyo, Tokyo, Japan) caliper, and 
the mean value was calculated (coefficient of variation value, 
9%).
Data analysis
The statistical analysis of the data was conducted using SPSS 
version 12.0 (SPSS Inc., Chicago, IL, USA). Data that followed 
a normal distribution are expressed as mean±standard devia-
tion, and variables that did not follow a normal distribution 
were logarithmically transformed prior to statistical analysis. 499
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Results are presented as medians (interquartile range). The 
characteristics of the GDM group and the NP control group 
were compared using an independent t-test. A linear regres-
sion analysis was used for women with a history of GDM in 
order to analyze the associations between CIMT and cardio-
vascular risk factors, and the association between CIMT and 
glucose intolerance was verified using ANOVA. 
RESULTS
Clinical characteristics of women with a history of GDM 
versus those of the NP control group
In this study, according to the physical measurements taken 
one year after delivery, the waist circumference of the females 
with a history of gestational diabetes group was thicker than 
that of the control group, but there was no difference in BMI 
or internal fat mass. In the results of the 75 g oral glucose tol-
erance test, the fasting plasma glucose levels were 100.2±15.1 
mg/dL in the GDM group vs. 91.0±8.1 mg/dL in the NP con-
trol group (P=0.011). Two hours after the glucose tolerance 
test, blood glucose levels were 136.2±39.9 mg/dL in the GDM 
group vs. 105.7±14.0 mg/dL in the NP group (P<0.001). The 
results from the GDM group were statistically and significant-
ly higher. The glycated hemoglobin levels were higher in the 
GDM group (6.3±1.1% in GDM vs. 5.9±0.5% in NP, P=0.096), 
but this difference was not statistically significant. The fasting 
plasma insulin concentration was 9.9 (6.8 to 15.3) μU/mL in 
the GDM group vs. 8.2 (6.8 to 8.8) μU/mL in the NP group 
(P=0.007), and the HOMA-IR results in women with a history 
of GDM appeared to be significantly higher: 2.25 (1.61 to 3.79) 
in the GDM group vs. 1.91 (1.41 to 2.00) in the NP group (P=
0.001). Total cholesterol, triglycerides, HDL-C and LDL-C 
concentrations were similar in both groups. When CIMT re-
sults from the GDM group were compared with those of the 
NP group, there did not appear to be a statistically significant 
difference: 0.435±0.054 mm in GDM vs. 0.460±0.046 mm in 
NP, respectively (P=0.069) (Table 1).
Cardiovascular risk factors that affect the CIMT of females 
with a history of gestational diabetes 
In order to determine the factors affecting CIMT in women 
with a history of GDM, a linear regression analysis that adjust-
ed for age was performed. Waist circumference, blood pressure, 
fasting glucose, fasting insulin, and lipids did not affect CIMT. 
However, as glycated hemoglobin increased, CIMT increased 
as well (P=0.011) (Table 2). When the glycated hemoglobin 
group was separated into two groups, a control group (glycat-
ed hemoglobin ≤6.0%) and a high glycated hemoglobin group 
(glycated hemoglobin >6.0%), and compared, the CIMT of 
the high glycated hemoglobin group was significantly thicker: 
0.420±0.047 mm vs. 0.448±0.057 mm, respectively (P=0.011) 
(Fig. 1).
Differences in CIMT based on glucose tolerance 
Among the 101 females who had histories of GDM, 94 re-
ceived a 75 g oral glucose tolerance test six weeks and again 
Table 1.  Comparison of clinical characteristics between those 
with previous GDM and the control group
Characteristic GDM (n=101) Control (n=19) P value
Age, yr 32.2±4.1 32.6±4.6 0.746
BMI, kg/m
2 22.3 (20.4-24.2) 20.4 (19.5-23.1) 0.082
Body weight, kg 53.8±15.2 53.6±7.1 0.954
Waist circumfer-
ence, cm
80.3±7.7 74.5±7.7 0.003
Visceral fat, cm
2 96.1±46.6 82.0±38.3 0.237
Subcutaneous fat, 
cm
2
228.7±94.5 218.2±68.5 0.660
SBP, mm Hg 110.2±16.5 106.6±7.7 0.352
DBP, mm Hg 66.5±10.3 65.8±6.4 0.776
FPG, mg/dL 100.2±15.1 91.0±8.1 0.011
2-hr glucose of 75 g 
OGTT, mg/dL
136.2±39.9 105.7±14.0 <0.001
HbA1c, % 6.3±1.1 5.9±0.5 0.096
Fasting insulin,  
μU/mL
9.9 (6.8-15.3) 8.2 (6.8-8.8) 0.007
Total cholesterol, 
mg/dL
184.6±28.0 189.8±35.1 0.625
Triglyceride, mg/dL 107.0 (79.5-137.5) 73.5 (62.0-102.0) 0.059
HDL-C, mg/dL 49.5 (43.3-60.0) 49.0 (46.0-65.3) 0.392
LDL-C, mg/dL 107.4±28.0 117.9±28.9 0.315
HOMA-IR 2.25 (1.61-3.79) 1.91 (1.41-2.00) 0.001
Carotid IMT, mm 0.435±0.054 0.460±0.046 0.069
Data characterized by normal distribution are expressed as mean± 
standard deviation. Parameters not normally distributed are expressed 
as median (interquartile range). 
GDM, gestational diabetes mellitus; BMI, body mass index; SBP, sys-
tolic blood pressure; DBP, diastolic blood pressure; FPG, fasting plas-
ma glucose; OGTT, oral glucose tolerance test; HDL-C, high density 
lipoprotein cholesterol; LDL-C, low density lipoprotein cholesterol; 
HOMA-IR, homeostatic model assessment–insulin resistance; IMT, 
intimal-medial thickness.500
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one year after delivery. When the glucose tolerance state was 
judged based on the test results after six weeks, 49 patients 
(52.1%) had normal glucose tolerance (NGT), 11 patients 
(11.7%) had impaired fasting glucose (IFG), 14 patients (14.9%) 
had impaired glucose tolerance (IGT), 16 patients (17.0%) had 
both impaired fasting glucose and impaired glucose tolerance 
(IFG/IGT) and four patients (4.3%) were diagnosed with dia-
betes (DM). After one year had passed, 31 patients (33.0%) 
had NGT, 16 patients (17.0%) had IFG, 16 patients (17.0%) 
had IGT, 22 patients (23.4%) had IFG/IGT and nine patients 
(9.6%) were diagnosed with DM. 
  No statistically significant difference was seen at six weeks or 
one year when the differences in IMT were compared among 
all five groups (Table 3). In addition, the results were the same 
whether the IFG group, IGT group, and the IFG/IGT group 
were analyzed together or separated into three groups (Table 
4). There was also no difference observed when the NGT and 
DM groups were compared (data not shown). 
DISCUSSION
Placental growth hormone and placental lactogen are hor-
mones produced by the placenta during pregnancy. During 
the late stages of pregnancy, the concentrations of insulin an-
tagonizing hormones, such as prolactin, cortisol and glucagon, 
and cytokines such as tumor necrosis factor-alpha (TNF-α) 
increase, and insulin resistance is lower [20-22]. During nor-
mal pregnancies, the compensatory insulin secretion from the 
pancreas increases. However, when adequate amounts of insu-
lin are not secreted to overcome the compensatory insulin re-
sistance, gestational diabetes occurs [23]. Compared with nor-
mal pregnancies, women who previously had GDM have a 
higher risk for developing type 2 diabetes, and as a result, fu-
ture risk of cardiovascular complications have been known to 
increase [24,25]. 
  In this study, the clinical characteristics of females who had 
gestational diabetes and of females with a normal pregnancy 
were compared. The results showed that, compared to normal 
pregnancies, women who had gestational diabetes had higher 
concentrations of insulin and had higher insulin resistance. As 
mentioned earlier, during pregnancy, the effects of several 
physiological hormones increase insulin resistance. Particu-
Table 2.  Associations between CIMT and cardiovascular risk 
factors in women with a history of GDM
Variable r
2 P value
BMI, kg/m
2 0.020 0.594
Body weight, kg 0.027 0.327
Waist circumference, cm 0.026 0.425
Visceral fat, cm
2 0.017 0.574
Subcutaneous fat, cm
2 0.013 0.912
SBP, mm Hg 0.025 0.186
DBP, mm Hg 0.024 0.199
FPG, mg/dL 0.017 0.216
2-hr glucose of 75 g OGTT, mg/dL 0.023 0.449
HbA1c, % 0.077 0.011
Fasting insulin, μU/mL 0.008 0.752
Total cholesterol, mg/dL 0.029 0.128
Triglyceride, mg/dL 0.037 0.079
HDL-C, mg/dL 0.015 0.299
LDL-C, mg/dL 0.014 0.314
HOMA-IR 0.018 0.649
Variables that were not normally distributed were logarithmically 
transformed before statistical analysis. Linear regression analysis was 
used to calculate r
2 and corresponding P values after controlling for 
age. 
GDM, gestational diabetes mellitus; BMI, body mass index; SBP, sys-
tolic blood pressure; DBP, diastolic blood pressure; FPG, fasting plas-
ma glucose; OGTT, oral glucose tolerance test; HDL-C, high density 
lipoprotein cholesterol; LDL-C, low density lipoprotein cholesterol; 
HOMA-IR, homeostatic model assessment–insulin resistance. 
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Fig. 1.  Difference in carotid artery intimal-medial thickness 
(CIMT) between normal and increased HbA1c groups in 
women with a history of gestational diabetes mellitus. In the 
women with a history of gestational diabetes mellitus, the CIMT 
of those in the high HbA1c group (HbA1c >6.0%) was higher 
than that of those women who had a normal HbA1c (HbA1c 
≤6.0%) (0.448±0.057 mm vs. 0.420±0.047 mm, P=0.010).501
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larly in patients with gestational diabetes who suffer from 
chronic insulin resistance, as physiological insulin resistance 
increases, they develop a higher level of insulin resistance 
compared to that in women with normal pregnancy [26-28], 
as was shown in the present study. 
  Considering that the patients with a history of gestational 
diabetes are at future risk for cardiovascular disease, we mea-
sured the CIMT in such patients, and the resulting correla-
tions with cardiovascular risk factors were analyzed. When a 
multiple linear regression analysis was performed, none of 
waist circumference, blood pressure, internal fat, HDL- and 
LDL-C or triglycerides showed a significant correlation with 
CIMT. However, as glycated hemoglobin increased, the CIMT 
significantly increased as well. In previous studies performed 
on people with impaired glucose tolerance, CIMT was report-
ed to increase as glycated hemoglobin increased [29], and stud-
ies targeting type 2 diabetes patients reported that there was a 
positive correlation between CIMT and glycated hemoglobin 
levels [30,31]. In the present study, a statistical significance in 
the increase in glycated hemoglobin levels and CIMT was ob-
served in women with a history of GDM. 
  In this study, we observed no difference in CIMT between 
the two study groups. When CIMT results of the GDM and 
control groups in Western countries were analyzed in a previ-
ous study, the results showed that women with histories of 
GDM were reported to have thicker CIMT measurements com-
pared to those of normal healthy females [14]. In that study, the 
group that had a history of gestational diabetes had a mean 
CIMT of 0.582±0.066 mm, while that of the control group 
was 0.543±0.049 mm, showing that the group with a history 
of GDM had significantly thicker CIMT [14]. However, in our 
study, the mean CIMT of women with history of GDM was 
0.435±0.054 mm, and the mean CIMT of the control group 
was 0.460±0.046 mm, which was significantly lower than those 
in the Western cases. Ethnic background and culturally-based 
obesity have been suggested as causes to explain this difference. 
One major factor that influences CIMT is obesity [32]. How-
ever, compared to Western populations, obesity is much less 
common in Koreans, in whom the average overall BMI is also 
much lower. The BMI of the GDM group and the NP group in 
this study fell within the normal range. By way of comparison, 
in the Western study [14], the mean BMI of the GDM group 
was 28.65±4.75 kg/m
2, and that of the control group was 
27.17±2.90 kg/m
2, which both fall in the overweight range. 
The differences in the weight ranges are believed to influence 
the CIMT measurements. In addition, the average BMI of the 
women who had a history of GDM in our study was low com-
pared to the average BMIs of study groups in other countries. 
Therefore, the inclusion of a high number of very lean GDM 
patients is considered to be a limitation which may have af-
fected the study results. 
  In addition, one thing that must be considered when inter-
preting the results for CIMT measurements is the age of our 
study population. The mean CIMTs of Korean females in their 
30s and 40s are 0.57±0.10 mm and 0.60±0.10 mm, respec-
tively, which seems to increase gradually with age [33]. Howev-
er, in the present study, the mean CIMT values of patients in 
their 30s were significantly lower than those of patients in 
Table 3.  Carotid IMT according to glucose tolerance status in women with a history of GDM (I)
NGT IFG IGT IFG/IGT DM P value
6w
a No. 49 11 14 16 4 0.506
IMT, mm 0.433±0.054 0.444±0.060 0.432±0.049 0.446±0.051 0.432±0.071
1y
b No. 31 16 16 22 9 0.218
IMT, mm 0.427±0.053 0.461±0.055 0.442±0.053 0.425±0.048 0.442±0.059
IMT, intimal-medial thickness; GDM, gestational diabetes mellitus; NGT, normal glucose tolerance; IFG, impaired fasting glucose; IGT, im-
paired glucose tolerance; DM, diabetes.
aAt post-partum six weeks, 
bAt post-partum one year.
Table 4.  Carotid IMT according to glucose tolerance status in 
women with a history of GDM (II)
NGT IFG or IGT DM P value
6w
a No. 49 41 4 0.790
IMT, mm 0.433±0.054 0.441±0.052 0.432±0.071
1y
b No. 31 54 9 0.506
IMT, mm 0.427±0.053 0.441±0.053 0.442±0.059
IMT, intimal-medial thickness; GDM, gestational diabetes mellitus; 
NGT, normal glucose tolerance; IFG, impaired fasting glucose; IGT, 
impaired glucose tolerance; DM, diabetes.
aAt post-partum six weeks, 
bAt post-partum one year.502
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their 40s. The mean age of the GDM group in this study was 
32.2±4.1 years, and the mean age of the NP group was 32.6± 
4.6 years. In addition, some patients were still in their 20s. Due 
to their young ages, their results were not considered to con-
tribute to the determination of significant changes in blood 
vessels due to arteriosclerosis. Finally, the size of the study 
groups could have influenced the results. There were 101 pa-
tients in the GDM group, but the NP group consisted of only 
19 patients.
  In this study, despite the similarities in CIMT results be-
tween the GDM groups and the NP group, the insulin resis-
tance of the GDM group was greater than that of the NP group, 
and we confirmed that increases in glycated hemoglobin oc-
curred with increases in CIMT in the GDM group. Consider-
ing the young age of the study group, it is difficult to observe a 
difference between the CIMT measurements of young women 
with history of GDM and women without, and there was no 
visible difference or correlation with existing known cardio-
vascular risk factors. Therefore, it was difficult to use CIMT as 
a measure to predict future risk of atherosclerosis. In addition, 
as seen in previous studies, one year after giving birth, the group 
that transitioned to diabetes was limited by its small size. When 
the significant correlation of CIMT and glycated hemoglobin 
in females with history of gestational diabetes who have in-
creasing insulin resistance and who are considered at high risk 
for cardiovascular disease is considered, those women can be 
expected to experience significant changes in CIMT and car-
diovascular risk factors. Therefore, in the examinations per-
formed shortly after giving birth in Korean women with histo-
ry of gestational diabetes, although CIMTs in the normal range 
and normal glucose tolerances were seen, as time passes and 
the rate of those who transition to diabetes increases, and when 
the accompaniment of hyperlipidemia and cardiovascular risk 
factors are considered, follow-up visits would be helpful. This 
study has been performing prospectively, the difference in 
CIMT between the transitioned to diabetes group and the non-
transitioned to diabetes group will be determined sooner or 
later. These findings should be considered in women with 
GDM.
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